Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](/images/stories/logo/lilly.gif)
Pfizer Reports Third-Quarter 2010 Revenues of $16.2 Billion
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](/images/stories/logo/pfizer_b.gif)
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Lundbeck expects to deliver solid profits during a period of new product launches and patent expiries
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](/images/stories/logo/lundbeck.gif)
Phase III ROCKET AF Study of Rivaroxaban meets its primary efficacy endpoint with Comparable Safety vs. Warfarin
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Nycomed to accelerate expansion in China
- Details
- Category: Nycomed
![Nycomed Nycomed](/images/stories/logo/nycomed.gif)
More Pharma News ...
- Novartis drug Afinitor® approved by FDA
- GlaxoSmithKline receives approval in Japan for two medicines: Revolade and Xyzal
- Sanofi-aventis to Acquire BMP Sunstone creating a Strong Consumer Healthcare Platform in China
- Merck KGaA Sells Théramex To Teva for EUR 265 million
- Bayer lifts sales and earnings again
- Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
- Bristol-Myers Squibb Third Quarter Featured Solid Operating Performance